Home

Samuel Whiting, Chief Medical Officer: Tempest Therapeutics TPST Buy · Filed 24/07/03

Trade details

Type
Insider buy
Amount
$9,951.36
Shares · price
4,672 sh · $2.13 a share
Held after
9,573 sh
Trade date
24/07/02
Filed
24/07/03
Days to filing
1 days

First buy since 2023

Insiders buying this week
3 insiders
Holding change
+95.3%

Tempest Therapeutics trades, last 26 weeks

What else happened in Tempest Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/02~24/08/01

Samuel Whiting's recent trades

No other trades yet.